• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.47% Nasdaq Up0.39%

    Protalix BioTherapeutics, Inc. (PLX)

    -NYSE MKT
    2.06 Up 0.01(0.49%) 4:02PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 1,384   3,707   2,686   7,383  
    Cost of Revenue1,577  1,798  1,605  4,073  
    Gross Profit (193) 1,909   1,081   3,310  
    Operating Expenses
    Research Development4,516  6,105  4,962  6,067  
    Selling General and Administrative2,372  2,012  1,566  3,711  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (7,081) (6,208) (5,447) (6,468)
    Income from Continuing Operations
    Total Other Income/Expenses Net57  (101)202  38  
    Earnings Before Interest And Taxes(7,024)(6,309)(5,245)(6,430)
    Interest Expense1,445  1,701  874  915  
    Income Before Tax(8,469)(8,010)(6,119)(7,345)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(8,469)(8,010)(6,119)(7,345)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (8,469) (8,010) (6,119) (7,345)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (8,469) (8,010) (6,119) (7,345)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.